Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3754005012 | Galcanezumab-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3754006013 | Product containing galcanezumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Galcanezumab-containing product | Has active ingredient | Galcanezumab | true | Inferred relationship | Some | 1 | |
| Galcanezumab-containing product | Is a | Product containing monoclonal antibody (product) | true | Inferred relationship | Some | ||
| Galcanezumab-containing product | Is a | Calcitonin gene-related peptide receptor antagonist-containing product | true | Inferred relationship | Some | ||
| Galcanezumab-containing product | Is a | Medicinal product acting as antimigraine agent (product) | false | Inferred relationship | Some | ||
| Galcanezumab-containing product | Plays role | Antimigraine therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only galcanezumab (medicinal product) | Is a | True | Galcanezumab-containing product | Inferred relationship | Some | |
| Product containing galcanezumab in parenteral dose form (medicinal product form) | Is a | True | Galcanezumab-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR